Phase II Study with Gemcitabine in Gallbladder and Biliary Tract Carcinomasa

Publisher： Karger

E-ISSN： 2296-5262|21|3|232-234

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.3, 1998-07, pp. : 232-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

Phase I study of gemcitabine, cisplatin, and S‐1 combination therapy for patients with untreated advanced biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 669-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study

By  

Oncology Research and Treatment, Vol. 34, Iss. 8-9, 2011-08 ,pp. : 469-470

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin, Epirubicin, and Continuous-Infusion 5-Fluorouracil for Advanced Biliary Tract Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 475-476

Karger

Access to resources Recommend Favorite

Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1456-1465

John Wiley & Sons Inc

Access to resources Recommend Favorite